These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38543175)

  • 21. Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor.
    Soumyanarayanan U; Ramanujulu PM; Mustafa N; Haider S; Fang Nee AH; Tong JX; Tan KSW; Chng WJ; Dymock BW
    Eur J Med Chem; 2019 Dec; 184():111755. PubMed ID: 31627059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel cyclic C
    Huber I; Pandur E; Sipos K; Barna L; Harazin A; Deli MA; Tyukodi L; Gulyás-Fekete G; Kulcsár G; Rozmer Z
    Eur J Pharm Sci; 2022 Jun; 173():106184. PubMed ID: 35413433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, in vitro and structural aspects of cap substituted Suberoylanilide hydroxamic acid analogs as potential inducers of apoptosis in Glioblastoma cancer cells via HDAC /microRNA regulation.
    Mekala JR; Ramalingam PS; Mathavan S; Yamajala RBRD; Moparthi NR; Kurappalli RK; Manyam RR
    Chem Biol Interact; 2022 Apr; 357():109876. PubMed ID: 35283086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-Carboline tethered cinnamoyl 2-aminobenzamides as class I selective HDAC inhibitors: Design, synthesis, biological activities and modelling studies.
    Namballa HK; Anchi P; Lakshmi Manasa K; Soni JP; Godugu C; Shankaraiah N; Kamal A
    Bioorg Chem; 2021 Dec; 117():105461. PubMed ID: 34753060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of trimetrexate cytotoxicity in vitro and in vivo by carboxypeptidase G2.
    Romanini A; Sobrero AF; Chou TC; Sherwood RF; Bertino JR
    Cancer Res; 1989 Nov; 49(21):6019-23. PubMed ID: 2529027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer.
    Duan YC; Jin LF; Ren HM; Zhang SJ; Liu YJ; Xu YT; He ZH; Song Y; Yuan H; Chen SH; Guan YY
    Eur J Med Chem; 2021 Aug; 220():113453. PubMed ID: 33957387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer.
    Bär SI; Dittmer A; Nitzsche B; Ter-Avetisyan G; Fähling M; Klefenz A; Kaps L; Biersack B; Schobert R; Höpfner M
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35485292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiproliferative and cytotoxic effects of sesquiterpene lactones isolated from
    Kovács B; Szemerédi N; Kúsz N; Kiss T; Csupor-Löffler B; Tsai YC; Rácz B; Spengler G; Csupor D
    Pharm Biol; 2022 Dec; 60(1):1511-1519. PubMed ID: 35952383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-clinical evaluation of LASSBio-1491: From in vitro pharmacokinetic study to in vivo leishmanicidal activity.
    de Queiroz AC; Barbosa G; de Oliveira VRT; de Mattos Alves H; Alves MA; Carregaro V; Santana da Silva J; Barreiro EJ; Alexandre-Moreira MS; Lima LM
    PLoS One; 2022; 17(6):e0269447. PubMed ID: 35666748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an
    Silva DKC; Teixeira JS; Moreira DRM; da Silva TF; Barreiro EJL; de Freitas HF; Pita SSDR; Teles ALB; Guimarães ET; Soares MBP
    Front Pharmacol; 2020; 11():590544. PubMed ID: 33390966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of a selective HDAC6 inhibitor active in neuroblasts.
    Zwick V; Simões-Pires CA; Nurisso A; Petit C; Dos Santos Passos C; Randazzo GM; Martinet N; Bertrand P; Cuendet M
    Bioorg Med Chem Lett; 2016 Oct; 26(20):4955-4959. PubMed ID: 27650925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
    Catchpoole DR; Stewart BW
    Cancer Res; 1993 Sep; 53(18):4287-96. PubMed ID: 8364925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxicity of three naturally occurring flavonoid derived compounds (artocarpesin, cycloartocarpesin and isobavachalcone) towards multi-factorial drug-resistant cancer cells.
    Kuete V; Mbaveng AT; Zeino M; Fozing CD; Ngameni B; Kapche GD; Ngadjui BT; Efferth T
    Phytomedicine; 2015 Nov; 22(12):1096-102. PubMed ID: 26547532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxicity of epunctanone and four other phytochemicals isolated from the medicinal plants Garcinia epunctata and Ptycholobium contortum towards multi-factorial drug resistant cancer cells.
    Mbaveng AT; Fotso GW; Ngnintedo D; Kuete V; Ngadjui BT; Keumedjio F; Andrae-Marobela K; Efferth T
    Phytomedicine; 2018 Sep; 48():112-119. PubMed ID: 30195869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC Inhibitors.
    Thakur A; Tawa GJ; Henderson MJ; Danchik C; Liu S; Shah P; Wang AQ; Dunn G; Kabir M; Padilha EC; Xu X; Simeonov A; Kharbanda S; Stone R; Grewal G
    J Med Chem; 2020 Apr; 63(8):4256-4292. PubMed ID: 32212730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer.
    Ma L; Bian X; Lin W
    J Exp Clin Cancer Res; 2020 Oct; 39(1):219. PubMed ID: 33069237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Image-guided synthesis reveals potent blood-brain barrier permeable histone deacetylase inhibitors.
    Seo YJ; Kang Y; Muench L; Reid A; Caesar S; Jean L; Wagner F; Holson E; Haggarty SJ; Weiss P; King P; Carter P; Volkow ND; Fowler JS; Hooker JM; Kim SW
    ACS Chem Neurosci; 2014 Jul; 5(7):588-96. PubMed ID: 24780082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxicity of the methanol extracts and compounds of Brucea antidysenterica (Simaroubaceae) towards multifactorial drug-resistant human cancer cell lines.
    Youmbi LM; Makong YSD; Mbaveng AT; Tankeo SB; Fotso GW; Ndjakou BL; Wansi JD; Beng VP; Sewald N; Ngadjui BT; Efferth T; Kuete V
    BMC Complement Med Ther; 2023 Feb; 23(1):48. PubMed ID: 36793009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma.
    Heider U; Rademacher J; Lamottke B; Mieth M; Moebs M; von Metzler I; Assaf C; Sezer O
    Eur J Haematol; 2009 Jun; 82(6):440-9. PubMed ID: 19220424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.